Document is current
Any future updates will be listed below
-
Authors
Benjamin, Neal R.
Crooijmans, Richard P. M. A. https://orcid.org/0000-0001-8108-9972
Jordan, Luke R.
Bolt, Courtni R.
Schook, Lawrence B. https://orcid.org/0000-0002-6580-8364
Schachtschneider, Kyle M. https://orcid.org/0000-0002-7293-8642
Groenen, Martien A. M. https://orcid.org/0000-0003-0484-4545
Roca, Alfred L. https://orcid.org/0000-0001-9217-5593
- License Information
-
More Information
Article History
Received: 2 May 2023
Accepted: 25 July 2023
First Online: 7 October 2023
Declarations
:
: KMS and LRJ receive research funding from Guerbet United States LLC, NeoTherma Oncology, and Janssen Research Development LLC. KMS is a VP of R&D and Services for Sus Clinicals, Inc. LRJ is Director of Product Development for Sus Clinicals, Inc. LBS receives research funding from Guerbet United States LLC, and NeoTherma Oncology. LBS is CSO for Sus Clinicals, Inc.
